Status:
TERMINATED
Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population
Lead Sponsor:
Picterus AS
Collaborating Sponsors:
Norwegian University of Science and Technology
Conditions:
Neonatal Jaundice
Eligibility:
All Genders
24-14 years
Phase:
NA
Brief Summary
The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara.
Detailed Description
The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara. The specific objectives for this study a...
Eligibility Criteria
Inclusion
- Infants born with gestational age ≥37 weeks
- Birth weight ≥2000g and ≤4500g
- Age 1 - 14 days
- Infants requiring a blood sample (newborn screening / clinically suspected jaundice)
Exclusion
- Infants transferred to the paediatric ward for advanced treatment.
- Infants with a skin rash or other disease that affects the skin where measurements are performed.
- Infants that receive or have received phototherapy in the last 24 hours.
- Infants with an inborn disease
Key Trial Info
Start Date :
May 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT05365399
Start Date
May 3 2022
End Date
August 15 2022
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mengo Hospital
Kampala, Uganda